Evidence map›Paper›PMID 40542333›Full record

ReviewRegenerative medicine2025

Toward equitable regenerative medicine: a health equity research framework for emerging regenerative treatments.

Mohamed Addani, Lindsay Beaman, Goldie Smith Byrd, Anthony Atala, Zubin Master

Abstract readReview
In one paragraph

Review in Regenerative medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mohamed AddaniClinical and Translational Science, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-0813-2078
Lindsay BeamanBiomedical Ethics Research Program, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-2729-1050
Goldie Smith ByrdMaya Angelou Research Center for Healthy Communities, Wake Forest University School of Medicine, Winston-Salem, NC, USA.ORCID 0000-0003-1057-0261
Anthony AtalaWake Forest Institute of Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.ORCID 0000-0001-8186-2160
Zubin MasterMaya Angelou Research Center for Healthy Communities, Wake Forest University School of Medicine, Winston-Salem, NC, USA.ORCID 0000-0002-3462-4546

Funding

Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Timothy Curry)UL1TR002377 · NCATS · MAYO CLINIC ROCHESTER · PI VESNA D GAROVIC · 2017 to 2026
$78.4M
Identifying salient factors that influence physician practices in mitigating patient misinformationR01AG083464 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MASTER, ZUBIN · 2024 to 2025
$1.4M
NCATS NIH HHS UL1 TR002377NIA NIH HHS R01 AG083464
6 · The paper itself

Abstract

Regenerative medicine continues to advance rapidly, yet research examining health disparities within this field remains notably limited. The distinctive characteristics of regenerative therapies - complex manufacturing, specialized delivery, and personalized approaches - present unique challenges for equitable health care access beyond traditional disparities. This gap is concerning as many conditions targeted by regenerative treatments disproportionately affect underserved populations. Our analysis of the literature identifies knowledge gaps and demonstrates the critical need for a multi-level approach to health equity research in regenerative medicine. We propose a research framework involving three key steps. First: systematic investigation of field-specific access barriers through established health disparity frameworks, focusing on factors uniquely relevant to regenerative therapies across individual, interpersonal, organizational, community, and societal levels. Second: development and rigorous evaluation of targeted, multi-level interventions addressing these barriers. Third: implementation of evidence-based strategies using equity-focused frameworks to translate findings into practice, ensuring equity considerations are embedded throughout development and delivery processes. By prioritizing health equity research while many regenerative treatments are still developing, the field has an unprecedented opportunity to create inclusive access pathways and ensure its potentially revolutionary therapies benefits all populations.

Indexed as

Healthcare DisparitiesHealth EquityRegenerative MedicineHealth Services AccessibilityHumansethicalhealth disparityhealth equitypolicyRegenerative medicine

Identifiers

PMID40542333
PMCPMC12269665

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.